(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

E1L3N

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

E1L3N

ST13

US500000086254212

Class

1

Filing

86254212

Registration

4597348

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

08/19/2025

Trademark type

Word

Nice classes

1

Filing date

04/16/2014

Registration date

09/02/2014

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/31/2025

Last transaction

08/19/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

04/05/2014

First use in commerce

04/05/2014

Drawing code

4

Owner type

03

Owner location

Danvers, MA

Examiner

SMITH, BRIDGETT

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Cell Signaling Technology, Inc.

Representatives

Keith A. Weltsch, Esq. Scully, Scott, Murphy and Presser, P.C.

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biochemicalsmonoclonal antibodies for in vitro scientific or research use; Laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use

Publications

History of USPTO decisions and trademark events.

26 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/31/2025

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

07/31/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/31/2025

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

06/06/2025

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

12/06/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/06/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

08/30/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/02/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/08/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/08/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/08/2022

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/23/2021

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/23/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/23/2021

E815

TEAS SECTION 8 & 15 RECEIVED

02/11/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/10/2020

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/02/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

09/02/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/17/2014

PUBO

PUBLISHED FOR OPPOSITION

06/17/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/28/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/07/2014

DOCK

ASSIGNED TO EXAMINER

05/05/2014

MPMK

NOTICE OF PSEUDO MARK E-MAILED

05/02/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/01/2014

NWAP

NEW APPLICATION ENTERED

04/19/2014

Continuous trademark protection

Get notified about every new filing that threatens E1L3N or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.